Literature DB >> 22372636

Mixtures of endocrine disrupting contaminants modelled on human high end exposures: an exploratory study in rats.

S Christiansen1, A Kortenkamp, M Axelstad, J Boberg, M Scholze, P R Jacobsen, M Faust, W Lichtensteiger, M Schlumpf, A Burdorf, U Hass.   

Abstract

By diminishing the action of androgens during gestation, certain chemicals can induce irreversible demasculinization and malformations of sex organs in the male rat after gestational exposure. Studies with mixtures of such anti-androgens have shown that substantial combined effects occur even though each individual chemical is present at low, ineffective doses, but the effects of mixtures modelled based on human intakes have not previously been investigated. To address this issue for the first time, we selected 13 chemicals for a developmental mixture toxicity study in rats where data about in vivo endocrine disrupting effects and information about human exposures was available, including phthalates, pesticides, UV-filters, bisphenol A, parabens and the drug paracetamol. The mixture ratio was chosen to reflect high end human intakes. To make decisions about the dose levels for studies in the rat, we employed the point of departure index (PODI) approach, which sums up ratios between estimated exposure levels and no-observed-adverse-effect-level (NOAEL) values of individual substances. For high end human exposures to the 13 selected chemicals, we calculated a PODI of 0.016. As only a PODI exceeding 1 is expected to lead to effects in the rat, a total dose more than 62 times higher than human exposures should lead to responses. Considering the high uncertainty of this estimate, experience on lowest-observed-adverse-effect-level (LOAEL)/NOAEL ratios and statistical power of rat studies, we expected that combined doses 150 times higher than high end human intake estimates should give no, or only borderline effects, whereas doses 450 times higher should produce significant responses. Experiments indeed showed clear developmental toxicity of the 450-fold dose in terms of increased nipple retention (NR) and reduced ventral prostate weight. The 150-fold dose group exhibited significantly increased NR. These observations suggest that highly exposed population groups, especially women of reproductive age, may not be protected sufficiently against the combined effects of chemicals that affect the hormonal milieu required for normal male sexual differentiation.
© 2012 The Authors. International Journal of Andrology © 2012 European Academy of Andrology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372636     DOI: 10.1111/j.1365-2605.2011.01242.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  24 in total

1.  Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.

Authors:  Russ Hauser; Niels E Skakkebaek; Ulla Hass; Jorma Toppari; Anders Juul; Anna Maria Andersson; Andreas Kortenkamp; Jerrold J Heindel; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2015-03-05       Impact factor: 5.958

2.  Assessment of occupational exposure to pesticide mixtures with endocrine-disrupting activity.

Authors:  Hie Ling Wong; David G Garthwaite; Carmel T Ramwell; Colin D Brown
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-17       Impact factor: 4.223

Review 3.  Falling sperm counts twenty years on: where are we now?

Authors:  R John Aitken
Journal:  Asian J Androl       Date:  2013-01-28       Impact factor: 3.285

4.  Dose Addition Models Based on Biologically Relevant Reductions in Fetal Testosterone Accurately Predict Postnatal Reproductive Tract Alterations by a Phthalate Mixture in Rats.

Authors:  Kembra L Howdeshell; Cynthia V Rider; Vickie S Wilson; Johnathan R Furr; Christy R Lambright; L Earl Gray
Journal:  Toxicol Sci       Date:  2015-09-08       Impact factor: 4.849

5.  Phthalate metabolite levels and menopausal hot flashes in midlife women.

Authors:  Ayelet Ziv-Gal; Lisa Gallicchio; Catheryne Chiang; Sara N Ther; Susan R Miller; Howard A Zacur; Russell L Dills; Jodi A Flaws
Journal:  Reprod Toxicol       Date:  2016-02-08       Impact factor: 3.143

Review 6.  Critical review and analysis of literature on low dose exposure to chemical mixtures in mammalian in vivo systems.

Authors:  Chris S Elcombe; Neil P Evans; Michelle Bellingham
Journal:  Crit Rev Toxicol       Date:  2022-07-27       Impact factor: 6.184

7.  Endocrine Disruption and Reproductive Pathology.

Authors:  Scott M Belcher; J Mark Cline; Justin Conley; Sibylle Groeters; Wendy N Jefferson; Mac Law; Emily Mackey; Alisa A Suen; Carmen J Williams; Darlene Dixon; Jeffrey C Wolf
Journal:  Toxicol Pathol       Date:  2019-12       Impact factor: 1.902

Review 8.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

9.  Concentration addition, independent action and generalized concentration addition models for mixture effect prediction of sex hormone synthesis in vitro.

Authors:  Niels Hadrup; Camilla Taxvig; Mikael Pedersen; Christine Nellemann; Ulla Hass; Anne Marie Vinggaard
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

10.  Selection of reference genes for quantitative RT-PCR (RT-qPCR) analysis of rat tissues under physiological and toxicological conditions.

Authors:  Terje Svingen; Heidi Letting; Niels Hadrup; Ulla Hass; Anne Marie Vinggaard
Journal:  PeerJ       Date:  2015-03-24       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.